Nuvectis Pharma Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$18.39

-10.14 (-35.54%)

As of Jun 30, 10:23 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 91%

Hold 1 9%

Sell 0 0%

Price Target

Analyst Price Target +49.0% upside

Low Target $23.46

Average Target $27.40

High Target $40.51

Current Price $18.39

Current
$18.39

Target
$27.40

$23.46 $27.40 avg $40.51

Scenario Analysis

Bear Case

$23.46

27.6%

Low target

Base Case

$27.40

+49.0%

Avg target

Bull Case

$40.51

+120.3%

High target

Risk/Reward

4.4x

Highly favorable

Price in Context

52-Week High

$27.93

-34.2% from high

52-Week Low

$5.55

+231.4% from low

Target vs 52W High

$27.40

-1.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%